Cleared Traditional

K881247 - MONO-PHILE

K881247 is the FDA 510(k) clearance for MONO-PHILE by Bio Diagnostic Systems, Inc.. It is a Class 2 Immunology device (product code KTN) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K881247 · Bio Diagnostic Systems, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1988
Decision
15d
Days
Class 2
Risk

K881247 is an FDA 510(k) clearance for the MONO-PHILE. Classified as System, Test, Infectious Mononucleosis (product code KTN), Class II - Special Controls.

Submitted by Bio Diagnostic Systems, Inc. (Princeton, US). The FDA issued a Cleared decision on April 7, 1988 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5640 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K881247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 1988
Decision Date April 07, 1988
Days to Decision 15 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 104d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KTN System, Test, Infectious Mononucleosis
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - KTN System, Test, Infectious Mononucleosis

All 28
Devices cleared under the same product code (KTN) and FDA review panel - the closest regulatory comparables to K881247.
MODIFICATION OF MONO-PLUS(TM)
K883709 · Armkel, LLC · Dec 1988
CARDS(TM) MONO
K884007 · Pacific Biotech, Inc. · Nov 1988
OXOID INFECTIOUS MONONUCLEOSIS KIT
K883540 · Unipath , Ltd. · Oct 1988
DIFFERENTIAL I.M. SCREENING TEST
K873297 · Sclavo, Inc. · Dec 1987
VENTRESCREEN (TM) MONO
K872032 · Ventrex Laboratories, Inc. · Jun 1987
MONO-LATEX (TM) SLIDE TEST
K862008 · Armkel, LLC · Jul 1986